How safe are environmental chemicals
Disciplines
Computer Sciences (65%); Medical-Theoretical Sciences, Pharmacy (35%)
Keywords
- In Silico Screening,
- Toxicology Predictions,
- Environmental Chemicals,
- Mechanism-Based Toxicity
We are directly exposed to a variety of diverse synthetic chemicals on a daily basis, for example when using cleaning products, cosmetics, drugs, plastics, and food additives. Many of these chemicals, e.g. environmental phenols, phthalates, and herbicides, can be detected in human blood or urine samples. Accordingly, due to the constant exposure to chemicals, it is essential to evaluate potential hazards and health risks. Within the EUs REACH program and the US National Toxicity Program, chemicals are studied for their potential endocrine disrupting effects. At the same time, alternatives to in vivo testing in the form of in silico / in vitro testing are evaluated. In silico predictions are highly useful to prioritize chemicals for in vitro / in vivo testing. Pharmacophore models are excellent in silico screening tools to select potentially active compounds from large chemical databases. However, so far they have hardly been used to suggest chemicals for toxicity evaluations. In the proposed project, a pharmacophore-based in silico screening platform will be developed to prioritize chemicals for mechanism-based toxicity evaluations. This platform will focus on 14 steroid- synthesizing and -metabolizing enzymes, which have not been considered in systematic toxicity studies so far. For each target, models will be experimentally validated to optimize their predictive power. Environmental chemical databases will be screened for potentially active compounds. Among the virtual hits, chemicals with direct consumer exposure or high annual production volume will be acquired and tested in vitro. Identified active chemical classes will be further investigated by testing structurally related compounds in the in vitro assays. Based on all experimental results, the pharmacophore models will be optimized to correctly separate active from inactive chemicals on the respective targets. For the studied chemical classes, structure-activity-relationship models will be built to further optimize the predictions within the respective compound class. The developed model collection and exemplified case studies will lay ground for future, systematic safety evaluations of chemicals. In the future, such in silico platforms combined with in vitro testing are expected to form one basis for toxicity predictions.
Safety of environmental chemicals The project "safety of environmental chemicals" aimed to identify chemicals, which may interfere with hormone homeostasis in the human body. For this, we aimed to establish computational models as pre-filters to focus time- and cost-intensive wet lab work on the most suspicious chemicals. We focused our investigations on industrial chemicals with high production volume in the EU, food contact materials, food additives such as conserving agents, substances used in cosmetic products, drugs and natural compounds, which are also used as food supplements. It is well known that chemicals can act like hormones themselves. However, the impact of chemicals on the biosynthesis and degradation of hormones has not been investigated that well. Synthesis and degradation, together called metabolism, are mediated by specific enzymes, which regulate the balance between active and inactive hormones in cells. The focus of this project lied on the potential inhibition of these enzymes by environmental chemicals. We developed a multi-step protocol for the selection of chemicals to test. First, we developed computational models for enzyme inhibition for essential enzyme involved in sex hormone biosynthesis. These models were extensively theoretically validated by classification experiments of known active and inactive compounds. Only models that passed these tests were further used in the project. Second, we selected chemicals with unknown effects on the enzymes for biological testing and evaluated, if the models could correctly predict the actual activity in vitro. Successful models were then employed predict potentially active compounds from environmental chemical databases. However, the main aim of this project was the development of high quality computational models, not (yet) their broad application to environmental chemicals - this will be scope of future projects. In the course of our proof of principle experiments, we could already identify several enzyme inhibitors among widely used chemicals. For example, parabens were discovered as a class of compounds inhibiting estrogen degradation. High intracellular estrogen levels may lead to adverse effects especially during sensitive phases in life just like pregnancy and puberty. They may promote feminization. However, parabens are degraded rapidly in the human body and the relevance of our finding must be evaluated by further experiments. The same is true for another chemical inhibiting estrogen degradation, ethyl vanillate, which is a flavoring agent sometimes used in chewing gum. Further examples include itraconazole and posaconazole, which can interfere with glucocorticoid balance. Especially during pregnancy, an excess of glucocorticoids can lead to disturbed development of the fetus. Finally, we identified epoxiconazole, an antifungal chemical used in agriculture, as inhibitor of cholesterol and aldosterone synthesis. This inhibition could influence the immune system and blood pressure regulation and needs follow-up studies to evaluate effects in vivo.
- Barbara Matuszczak, Universität Innsbruck , associated research partner
- Klaus Schleifer, BASF Ludwigshafen - Germany
- Jerzy Adamski, Helmholtz Zentrum München - Germany
- Johannes Kirchmair, Universität Hamburg - Germany
- Rolf Wolfgang Hartmann, Universität des Saarlandes - Germany
- Alex Odermatt, Universität Basel - Switzerland
- Paul Foster, The University of Birmingham
Research Output
- 466 Citations
- 32 Publications
- 2 Scientific Awards
- 3 Fundings
-
2015
Title Pharmacophore Models and Pharmacophore-Based Virtual Screening: Concepts and Applications Exemplified on Hydroxysteroid Dehydrogenases DOI 10.3390/molecules201219880 Type Journal Article Author Kaserer T Journal Molecules Pages 22799-22832 Link Publication -
2015
Title Prospective performance evaluation of selected common virtual screening tools. Case study: Cyclooxygenase (COX) 1 and 2 DOI 10.1016/j.ejmech.2015.04.017 Type Journal Article Author Kaserer T Journal European Journal of Medicinal Chemistry Pages 445-457 Link Publication -
2015
Title In Silico Predictions of Drug – Drug Interactions Caused by CYP1A2, 2C9 and 3A4 Inhibition – a Comparative Study of Virtual Screening Performance DOI 10.1002/minf.201400192 Type Journal Article Author Kaserer T Journal Molecular Informatics Pages 431-457 -
2015
Title Pharmacophore models and pharmacophore-based virtual screening; In: In Silico Drug Discovery and Design: Theory, Methods, Challenges and Applications Type Book Chapter Author Akram M Publisher CRC Press Pages 123-153 -
2015
Title Modeling modulators of steroid hormone actions: receptor ligands and biotransformation inhibitors Type Other Author Vuorinen Ae -
2015
Title Establishing an optimized in silico workflow for activity profiling Type Other Author Kaserer T -
2015
Title Computer-aided discovery of novel 17-hydroxysteroid dehydrogenase type 4 (17-HSD4) inhibitors Type Conference Proceeding Abstract Author Kaserer T Conference 3rd Congress on Steroid Research, 5.-18.11.2015; Chicago, USA -
2015
Title Pharmacophore Modeling and virtual screening to discover cytochrome P450 17 inhibitors among environmental chemicals Type Conference Proceeding Abstract Author Akram M Conference 29th Molecular Modeling Workshop; 09.-11.03.2015; Erlangen, Germany -
2015
Title Molecular modeling of cytochrome P450 17 inhibitors for predicting the toxic effects of environmental chemicals Type Conference Proceeding Abstract Author Akram M Conference MCBO Science Day & 7th Life Science Day; 27.02.2015; Innsbruck, Austria -
2015
Title Pharmacophore model-based identification of environmental chemicals inhibiting hydroxysteroid dehydrogenases Type Conference Proceeding Abstract Author Schuster D Conference 3rd Congress on Steroid Research; 15.-18.11.2015; Chicago, Illinois, USA -
2014
Title Hydroxysteroid dehydrogenase inhibitors as potential endocrine disrupting agents Type Conference Proceeding Abstract Author Akram M Conference 6th Life Science Meeting; 24.-25.09.2014; Innsbruck -
2019
Title Fingerprints and Pharmacophores; In: Fingerprints and pharmacophores Type Book Chapter Author Schuster D Publisher Elsevier Pages 619-627 -
2019
Title Identification of the fungicide epoxiconazole as inhibitor of human 11ß-hydroxylase and aldosterone synthase Type Conference Proceeding Abstract Author Akram M Conference 10. Paracelsus Science Get Together -
2019
Title Identification of the fungicide epoxiconazole by virtual screening and biological assessment as inhibitor of human 11ß-hydroxylase and aldosterone synthase Type Conference Proceeding Abstract Author Akram M Conference 26th Scientific Congress of the Austrian Pharmaceutical Society -
2018
Title Pharmacophore Models for Toxicology Prediction; In: Computational Toxicology: Risk Assessment for Chemicals Type Book Chapter Author Schuster D Publisher John Wiley & Sons, Inc. Pages 121-144 -
2018
Title The anti-fungal epoxiconazole inhibits human CYP P450 11B1 and CYP P450 11B2: Virtual screening as a tool to find potential endocrine disruptors Type Conference Proceeding Abstract Author Akram M Conference Paracelsus Science Get Together 2018 -
2018
Title Development and validation of pharmacophore models for human cytochrome P450 11 B1 and P450 11B2 inhibition Type Conference Proceeding Abstract Author Akram M Conference Paracelsus Science Get Together 2018 -
2017
Title Three dimensional pharmacophore modeling and model validation of human CYP11B1 and CYP11B2 inhibition, potential targets for treating Cushing's syndrome and congestive heart failure Type Conference Proceeding Abstract Author Akram M Conference Pharma 2030 - Current and Future Challenges -
2017
Title Docking of azole fungicides into human 11-HSD1, 11-HSD2 and murine 11-HSD2 Type Conference Proceeding Abstract Author Beck Kr Conference Pharma 2030 - Current and Future Challenges -
2017
Title Pharmacophore modeling and virtual screening for 17beta-hydroxysteroid dehydrogenase 7 inhibitors Type Other Author Fiala J -
2017
Title Pharmacophore Modeling and in Silico/in Vitro Screening for Human Cytochrome P450 11B1 and Cytochrome P450 11B2 Inhibitors DOI 10.3389/fchem.2017.00104 Type Journal Article Author Akram M Journal Frontiers in Chemistry Pages 104 Link Publication -
2017
Title Interference of Paraben Compounds with Estrogen Metabolism by Inhibition of 17ß-Hydroxysteroid Dehydrogenases DOI 10.3390/ijms18092007 Type Journal Article Author Engeli R Journal International Journal of Molecular Sciences Pages 2007 Link Publication -
2017
Title Inhibition of 11ß-hydroxysteroid dehydrogenase 2 by the fungicides itraconazole and posaconazole DOI 10.1016/j.bcp.2017.01.010 Type Journal Article Author Beck K Journal Biochemical Pharmacology Pages 93-103 Link Publication -
2019
Title Identification of the fungicide epoxiconazole by virtual screening and biological assessment as inhibitor of human 11ß-hydroxylase and aldosterone synthase DOI 10.1016/j.jsbmb.2019.04.007 Type Journal Article Author Akram M Journal The Journal of Steroid Biochemistry and Molecular Biology Pages 105358 -
2016
Title Pharmacophore modeling and virtual screening for 3beta-hydroxysteroid dehydrogenase inhibitors Type Other Author Kurzemann F -
2016
Title Construction of an industrial-chemical database including screening against anti-targets Type Other Author Lazic B -
2016
Title Inhibition of 11 beta-hydroxysteroid dehydrogenase 2 by the fungicides itraconazole and posaconazole Type Conference Proceeding Abstract Author Beck Kr Conference 52nd Congress of the European Societies of Toxicology (EUROTOX) Link Publication -
2016
Title Evaluation of selected 3D virtual screening tools for the prospective identification of peroxisome proliferator-activated receptor (PPAR) ? partial agonists DOI 10.1016/j.ejmech.2016.07.072 Type Journal Article Author Kaserer T Journal European Journal of Medicinal Chemistry Pages 49-62 Link Publication -
2016
Title Evaluation of tetrabromobisphenol A effects on human glucocorticoid and androgen receptors: A comparison of results from human- with yeast-based in vitro assays DOI 10.1016/j.tox.2016.09.014 Type Journal Article Author Beck K Journal Toxicology Pages 70-77 Link Publication -
2014
Title Ligand-Based Pharmacophore Modeling and Virtual Screening for the Discovery of Novel 17ß-Hydroxysteroid Dehydrogenase 2 Inhibitors DOI 10.1021/jm5004914 Type Journal Article Author Vuorinen A Journal Journal of Medicinal Chemistry Pages 5995-6007 Link Publication -
2017
Title Potential Antiosteoporotic Natural Product Lead Compounds That Inhibit 17ß-Hydroxysteroid Dehydrogenase Type 2 DOI 10.1021/acs.jnatprod.6b00950 Type Journal Article Author Vuorinen A Journal Journal of Natural Products Pages 965-974 Link Publication -
2017
Title Virtual screening applications in short-chain dehydrogenase/reductase research DOI 10.1016/j.jsbmb.2017.03.008 Type Journal Article Author Beck K Journal The Journal of Steroid Biochemistry and Molecular Biology Pages 157-177 Link Publication
-
2017
Title Speaker at the ALUMNI meeting at the Technical University of Dresden, Germany Type Personally asked as a key note speaker to a conference Level of Recognition Regional (any country) -
2015
Title Invited speaker at the National Doctoral Program in Informational and Structural Biology (ISB) 2015 Winter School, Finland :Environmental chemicals disturbing hormone homeostasis: pharmacophore-based identification and examples Type Personally asked as a key note speaker to a conference Level of Recognition National (any country)
-
2016
Title Erasmus+ fellowship to Muhammad Akram Type Fellowship Start of Funding 2016 Funder Standortagentur Tirol -
2017
Title Erasmus+ fellowship to Muhammad Akram Type Fellowship Start of Funding 2017 Funder Standortagentur Tirol -
2016
Title Ingeborg Hochmair Professorship (5 year full professorship salary sponsored by MedEl) Type Fellowship Start of Funding 2016 Funder University of Innsbruck